Interferon-gamma response by years after tuberculosis infection, measured with QuantiFERON-TB Plus

K. Takeda (Tokyo, Japan), H. Nagai (Tokyo, Japan), M. Suzukawa (Tokyo, Japan), K. Higa (Tokyo, Japan), S. Akashi (Tokyo, Japan), M. Kawashima (Tokyo, Japan), N. Ohshima (Tokyo, Japan), A. Yamane (Tokyo, Japan), A. Tamura (Tokyo, Japan), H. Matsui (Tokyo, Japan), S. Tohma (Tokyo, Japan)

Source: International Congress 2019 – Tuberculosis: diagnosis
Session: Tuberculosis: diagnosis
Session type: Thematic Poster
Number: 3005
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Takeda (Tokyo, Japan), H. Nagai (Tokyo, Japan), M. Suzukawa (Tokyo, Japan), K. Higa (Tokyo, Japan), S. Akashi (Tokyo, Japan), M. Kawashima (Tokyo, Japan), N. Ohshima (Tokyo, Japan), A. Yamane (Tokyo, Japan), A. Tamura (Tokyo, Japan), H. Matsui (Tokyo, Japan), S. Tohma (Tokyo, Japan). Interferon-gamma response by years after tuberculosis infection, measured with QuantiFERON-TB Plus. 3005

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection
Source: Eur Respir J 2013; 41: 909-916
Year: 2013



QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019

Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment
Source: International Congress 2017 – Migrants and screening
Year: 2017

Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011


Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Evaluation of cut-off values of QuantiFERON-TB Gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012

QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
Source: Eur Respir J 2009; 33: 586-593
Year: 2009



Discordance QuantiFERON-TB Gold in-tube and tuberculin skin test: Latent tuberculosis infection or immunological memory?
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013


Role of the QuantiFERON®-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection
Source: Eur Respir J 2012; 40: 1443-1449
Year: 2012



Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005


Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012



Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012



QuantiFERON-TB Gold for detection of latent and active tuberculosis infection in immunocompromised versus immune-competent
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010

Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010


Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool
Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016
Year: 2017


Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009